Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06137014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fortified Oral Rehydration Therapy for Pediatric Diarrhea

Study acronym: fORT
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Jul 2026 to Jun 2027
    v3
  2. Notable Lead sponsor: Paul Breslin, PhD to Paul A Breslin
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2023 to Jun 1, 2024
    • Study sites: 0 to 1
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare amino acid-fortified oral rehydration therapy (ORT) to the standard of care ORT in pediatric patients with acute gastroenteritis (AGE). The main questions it aims to answer are: * can amino acid-fortified ORT reduce the duration and severity of AGE compared to standard of care ORT? * can amino acid-fortified ORT increase the secretion of antimicrobial peptides in the gastrointestinal tract compared to standard of care ORT? Participants will be assigned to the experimental treatment (amino acid-fortified ORT) or the standard of care ORT and their disease severity, duration, and stool antimicrobial peptide content.
Trial Details
NCT Number NCT06137014
Lead Sponsor Paul A Breslin
Collaborators: The Gerber Foundation
Conditions
(from sponsor)
Acute Gastroenteritis
Related terms Diarrhea, Infantile, Gastroenteritis, Intestinal Diseases
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov